Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-SITAGLIPTIN MALATE / METFORMIN DIN 02520494

Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: SITAGLIPTIN (SITAGLIPTIN MALATE)
Available to quote

Health Canada record

Active ingredient(s)SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA10BD07 METFORMIN AND SITAGLIPTIN
Original market date24-Sep-2024
Current status date24-Sep-2024
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SITAGLIPTIN (SITAGLIPTIN MALATE)

DINProductCompanyFormStrengthStatus
02508656APO-SITAGLIPTIN MALATEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 25 MGMarketed
02508664APO-SITAGLIPTIN MALATEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MGMarketed
02508672APO-SITAGLIPTIN MALATEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 100 MGMarketed
02509415APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MGMarketed
02509423APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MGMarketed
02509431APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INCTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MGMarketed
02522705TEVA-SITAGLIPTIN MALATETEVA CANADA LIMITEDTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 25 MGMarketed
02522713TEVA-SITAGLIPTIN MALATETEVA CANADA LIMITEDTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MGMarketed
02522721TEVA-SITAGLIPTIN MALATETEVA CANADA LIMITEDTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 100 MGMarketed
02520508TEVA-SITAGLIPTIN MALATE / METFORMINTEVA CANADA LIMITEDTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MGMarketed
02520516TEVA-SITAGLIPTIN MALATE / METFORMINTEVA CANADA LIMITEDTabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MGMarketed
02534304PRO-SITAGLIPTIN MALATEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MGCancelled Post Market
02534312PRO-SITAGLIPTIN MALATEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 100 MGCancelled Post Market
02534290PRO-SITAGLIPTIN MALATEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 25 MGCancelled Post Market
02534223PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MGCancelled Post Market
02534231PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MGCancelled Post Market
02534258PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEPRO DOC LIMITEETabletSITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
298282023-01-05Abbreviated New Drug Submission (ANDS)
Request a quote for TEVA-SITAGLIPTIN MALATE / METFORMIN

How to read a Canadian DIN record